Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Ara

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 26, 2006
Assessment of clinical and economic benefits of weight management with sibutramine in general practice in GermanyAlan Brennan, Roberta Ara, Raimund Sterz, et al.
Applied Health Economics and Health Policy|April 2, 2017
Predicting Productivity Losses from Health-Related Quality of Life Using Patient DataClara Mukuria, Donna Rowen, Mónica Hernández-Alava, et al.
Clinical and Experimental Rheumatology|March 14, 2012
Healthcare costs and productivity losses directly attributable to ankylosing spondylitisRachid Rafia, Roberta Ara, Jon Packham, et al.
Pharmacoeconomics|January 31, 2009
Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysisNick Bansback, Roberta Ara, Sue Ward, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?Roberta Ara, Harry Hill, Andrew Lloyd, et al.
BMJ Open|September 28, 2016
Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trialPadraig Dixon, Sandra Hollinghurst, Roberta Ara, et al.
Rheumatology (Oxford, England)|June 29, 2010
Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKChris D Poole, Max Lebmeier, Roberta Ara, et al.
Applied Health Economics and Health Policy|April 5, 2019
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility ValuesClara Mukuria, Donna Rowen, Sue Harnan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
The CHD challenge: comparing four cost-effectiveness modelsDavid Turner, James Raftery, Keith Cooper, et al.
Pharmacoeconomics|June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluationsBen Kearns, Roberta Ara, Allan Wailoo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 26, 2006
Assessment of clinical and economic benefits of weight management with sibutramine in general practice in GermanyAlan Brennan, Roberta Ara, Raimund Sterz, et al.
Applied Health Economics and Health Policy|April 2, 2017
Predicting Productivity Losses from Health-Related Quality of Life Using Patient DataClara Mukuria, Donna Rowen, Mónica Hernández-Alava, et al.
Clinical and Experimental Rheumatology|March 14, 2012
Healthcare costs and productivity losses directly attributable to ankylosing spondylitisRachid Rafia, Roberta Ara, Jon Packham, et al.
Pharmacoeconomics|January 31, 2009
Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysisNick Bansback, Roberta Ara, Sue Ward, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?Roberta Ara, Harry Hill, Andrew Lloyd, et al.
BMJ Open|September 28, 2016
Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trialPadraig Dixon, Sandra Hollinghurst, Roberta Ara, et al.
Rheumatology (Oxford, England)|June 29, 2010
Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKChris D Poole, Max Lebmeier, Roberta Ara, et al.
Applied Health Economics and Health Policy|April 5, 2019
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility ValuesClara Mukuria, Donna Rowen, Sue Harnan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
The CHD challenge: comparing four cost-effectiveness modelsDavid Turner, James Raftery, Keith Cooper, et al.
Pharmacoeconomics|June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluationsBen Kearns, Roberta Ara, Allan Wailoo, et al.
Pageof 4